Collaborative Research and Development Agreements and Strategic Partnership Programs
Collaborative Research and Development Agreements (CRADAs) and Strategic Partnership Programs (SPPs) are mechanisms under which the ABF can work together with Industry.
SPPs tend to be smaller engagements and often involve the ABF performing a single unit operation (e.g., targeted proteomics analysis) for the Industrial Partner. SPPs may be very attractive to Industry, as the Industrial Partner retains all intellectual property (IP) rights derived from the work performed. CRADAs tend to be larger engagements involving the ABF performing multiple unit operations in collaboration with the Industrial Partner (which may embed its staff at ABF facilities while pursuing the scope of the project’s work).
Under CRADAs, IP ownership follows inventorship, with the Industrial Partner generally having an option to negotiate an exclusive license to ABF (co-)invented IP in specific field(s) of use. There may be certain other restrictions placed on CRADAs and SPPs, for example the scope of the project’s work must only include domain expertise and capabilities exclusively/uniquely available from the ABF national labs (i.e., are not otherwise commercially available), and developed processes/products that are derivative of the work performed may need to be first substantially implemented/manufactured in the United States.
Agile BioFoundry (ABF) Researchers are free to collaborate with other researchers from within academic/non-profit/government institutions, with the work either needing to be directly aligned with the ABF’s mission, or the collaborating parties required to secure additional sources of funding to pursue the collaborative work.